A Lackluster JPM and a Troubling future for Fate Therapeutics

Biotech Bros

English - January 16, 2023 12:00 - 56 minutes - 38.8 MB
Investing Business Health & Fitness Medicine biotech investing money finance get rich markets comedy health healthcare Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: The Importance of Value Perception in Biotech with Samina Bari

Next Episode: CRL for Eli Lilly and Leap Therapeutics Searches for a Flame?

This week on the podcast Agustin discusses the excitement for 2023 in biotech investing and highlights some key tailwinds that could provide a return to positive returns for investors. He also discusses the rather lackluster JPM conference and highlights the troubles plaguing Fate Therapeutics and other natural killer cell therapy companies.

If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com

Twitter Mentions

@biotech_bros